Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

News

XenoGesis Founder and CEO, Richard Weaver, has been named Director of the Year at the Institute of Directors East Midlands Awards 2019, in the SME business (Small) category. Held at Winstanley House, Leicestershire, the awards celebrated the most dynamic and inspiring directors in the region. Forty-six of...

AdamsonJones, a growing East-Midlands based firm of patent attorneys and trade mark attorneys, is pleased to announce that David Gwilliam, Eilidh Pugh and Jenny Vaughan have all been promoted to the position of Partner. These new promotions strengthen the firm’s life sciences team, an area of...

Business support is now available for life science companies in the South East Midlands, thanks to a project delivered by Medilink East Midlands and part-funded by the European Regional Development Fund (ERDF). ACTIS is a £2.1 million scheme, part-funded by ERDF, to provide support for eligible...

Platelet specialists Dr Natalia Dovlatova, Ann White and Bob Humphries announce the launch of their new company – ‘Platelet Services Limited’, which will be based in BioCity Nottingham, UK. Collectively, the team has decades of experience in the application of platelet function testing to drug...

BioCity, the pioneering life science and business collective has announced co-investment into Rinri Therapeutics. A biotechnology company developing a novel cell-based therapy to restore hearing, Rinri Therapeutics have successfully secured £1.4 million in seed funding. BioCity’s recent investment in the biotech company, marks the 28th investment...

Nottingham-based leading DMPK provider, XenoGesis has reported a 78% increase in its exports from last year, with half of its revenue now coming from overseas. Founded in 2011, XenoGesis now has clients across six continents and has experienced consistent growth since day one, with export revenue...